A carregar...
Nafamostat mesylate-induced hyperkalemia in critically ill patients with COVID-19: Four case reports
BACKGROUND: Nafamostat mesylate (NM) may prove to be one of the key drugs effective against coronavirus disease 2019 (COVID-19) because of its anti-viral properties and the potential to manage coagulopathy. However, NM tends to increase serum potassium levels. CASE SUMMARY: We observed hyperkalemia...
Na minha lista:
| Publicado no: | World J Clin Cases |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7674713/ https://ncbi.nlm.nih.gov/pubmed/33269265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v8.i21.5320 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|